A tandem mass spectrometric approach to the identification of O‐glycosylated glargine glycoforms in active pharmaceutical ingredient expressed in Pichia pastoris
- 2 March 2009
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 23 (7) , 1035-1042
Abstract
Glycoforms of glargine expressed in Pichia pastoris were isolated by high‐performance liquid chromatography and analyzed by a series of chemical and mass spectrometric methods for the identification of various glycoforms, glycosylation position, nature and structure of glycans. Reduction and alkylation, peptide mapping techniques were used to decipher the amino acid site at which glycosylation had taken place. Chemical methods were coupled with mass spectrometry techniques such as electrospray ionization and matrix‐assisted laser desorption/ionization for identification of the glycosylation site. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 25 references indexed in Scilit:
- Yeast Glycobiology and Its ApplicationBioscience, Biotechnology, and Biochemistry, 2008
- Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial*Diabetes, Obesity and Metabolism, 2008
- Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trialThe Lancet, 2008
- Modern insulins—comment on facts and assumptions in a recent EditorialDiabetologia, 2008
- Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitusArchives of Physiology and Biochemistry, 2008
- Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 DiabetesDiabetes Care, 2007
- Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccinesVaccine, 2007
- An Update on the Long-Acting Insulin Analogue GlargineBasic & Clinical Pharmacology & Toxicology, 2006
- Mass spectrometric profiling of O‐linked glycans released directly from glycoproteins in gels using in‐gel reductive β‐eliminationProteomics, 2006
- The role of mass spectrometry in the study of non‐enzymatic protein glycation in diabetes: An updateMass Spectrometry Reviews, 2006